Skip to main content
  • Book
  • © 2015

ACEi and ARBS in Hypertension and Heart Failure

  • Presents highly practical information on the appropriate use of RAS antagonists in cardiovascular diseases
  • Emphasis is on a just-the-facts clinical approach
  • Describes clinical indications of ACEi and ARBs in heart failure and hypertension patients
  • Contains expert analyis from world renowned authorship
  • Includes supplementary material: sn.pub/extras

Part of the book series: Current Cardiovascular Therapy (CCT, volume 5)

Buy it now

Buying options

eBook USD 44.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (4 chapters)

  1. Front Matter

    Pages i-x
  2. ACE Inhibitor and Renin–Angiotensin System the Cornerstone of Therapy for Systolic Heart Failure

    • Claudio Borghi, Filippo Del Corso, Simone Faenza, Eugenio Cosentino
    Pages 41-72
  3. Impact of Chronic Kidney Disease and Diabetes Mellitus on Choice of Renin Angiotensin System-Inhibitors in Patients with Hypertension and Heart Failure

    • Pantelis A. Sarafidis, Panagiotis I. Georgianos, Pantelis E. Zebekakis, Athanasios J. Manolis
    Pages 73-118
  4. Target Organ Damage and RAAS Blockade

    • Ilaria Spoletini, Cristiana Vitale, Giuseppe M. C. Rosano
    Pages 119-148
  5. Back Matter

    Pages 149-150

About this book

The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction. Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It will be presented as highly practical information on this topic, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose. The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series and this title is no exception. It will contain practical illustrations and is designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas.

Editors and Affiliations

  • Cardiology School Federico II University of Naples, Naples, Italy

    Pasquale Perrone Filardi

About the editor

Pasquale Ferrone Filardi is an Associate Professor of Cardiology and head of the Cardiology School at the University of Naples, Italy.

Bibliographic Information

  • Book Title: ACEi and ARBS in Hypertension and Heart Failure

  • Editors: Pasquale Perrone Filardi

  • Series Title: Current Cardiovascular Therapy

  • DOI: https://doi.org/10.1007/978-3-319-09788-6

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing Switzerland 2015

  • Softcover ISBN: 978-3-319-09787-9Published: 03 November 2014

  • eBook ISBN: 978-3-319-09788-6Published: 16 October 2014

  • Series ISSN: 2946-8183

  • Series E-ISSN: 2946-8191

  • Edition Number: 1

  • Number of Pages: X, 150

  • Number of Illustrations: 6 b/w illustrations, 13 illustrations in colour

  • Topics: Cardiology, Pharmacotherapy

Buy it now

Buying options

eBook USD 44.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access